ArticlePLOS global public health2025
Coverage and contextual factors associated with insecticide-treated net use among women of reproductive age in Nigeria: evidence from the 2021 malaria indicator survey data.
Article in PLOS global public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Determinants of Knowledge of Malaria Prevention Among Women of Reproductive Age 15-49 Years in Nigeria.Nigerian medical journal : journal of the Nigeria Medical AssociationReview
- Determinants of Malaria Insecticide-Treated Nets Use Among Women of Reproductive Age in Nigeria.Nigerian medical journal : journal of the Nigeria Medical AssociationReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nigeria continues to face a serious public health problem due to malaria, which contributes around 27% of all cases worldwide. Although insecticide-treated nets (ITNs) are essential interventions for preventing malaria, their use in Nigeria is still sub-optimal. Understanding the factors influencing ITN use is essential to improve malaria control strategies. This study aimed to investigate the prevalence of and factors associated with ITN use among women of reproductive age in Nigeria. We conducted a secondary data analysis of the 2021 Malaria Indicator Survey (NMIS). The sample included 14,476 women of reproductive age (15-49 years) from 567 clusters across Nigeria's six geopolitical zones. Multilevel logistic regression was used to examine the contextual factors associated with ITN use, accounting for both fixed and random effects. Statistical significance was set at p<0.05, with 95% confidence intervals reported for all estimates. The weighted prevalence of ITN use was 41.5% (95% CI: 39.7, 43.3). The results showed Muslim women had 21% (aOR= 0.79; 95% CI: 0.67-0.94) lower odds of ITN use, when compared with the Christian women. Those who had living children were more likely to report ITN use, when compared with women with no child. The non-poor women had higher odds of ITN use, when compared with the poor women (aOR= 1.35; 95% CI: 1.19-1.52). In addition, women from multi-ethnic had 26% lower odds of ITN use, when compared with those from mono-ethnic community (aOR= 0.74; 95% CI: 0.57-0.94). The geographical region was significantly associated with ITN use among Nigerian women. Those from high-level community poverty had 53% reduction in the odds of ITN use, when compared with women from low-level community poverty (aOR= 0.47; 95% CI: 0.32-0.68). ITN use among women of reproductive age in Nigeria remained below the national target. Interventions to increase ITN use should consider the complex interplay of individual and community-level factors. Targeted strategies addressing socioeconomic disparities, leveraging cultural contexts, and implementing community-based approaches are crucial for improving ITN utilization and reducing the malarial burden in Nigeria.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.